deviation). Results: A total of 75 patients (83% female) met the inclusion criteria with 67% completing the DLQI assessment. The mean number of treatments over the study period was 12 (AE 3.1) while mean age was 37.6 years (AE 8.82). Mean overall DLQI score was 1.6 (AE 2.01), which was an improvement of mean overall score of 12.2 (AE 8.0) from previously published validated data. Relationship related scores were mean 0.53 (AE 0.8). Conclusion: These data suggest that known benefits of botulinum toxin treatment on QOL are sustained in the long term. However, there is a requirement for randomised data to confirm this hypothesis.
CSHA) mFI) is a verified, practical system consisting of 11 items. Three hundred and eighty-four patients referred to the vascular clinics with a diagnosis of AAA over the past three years were included. Of those unfit for surgery and/or continued surveillance, records for positive mFI features were retrospectively reviewed. Results: A total of 63 patients fit the criteria. 39 patients were <5.5cm; seven (11.1%) were small (<4cm), seven (11.1%) declined surveillance and 25 (39.7%) were withdrawn from surveillance due to co-morbidities. These 25 patients had an average of 2.9 mFI items. 24 patients had an AAA >5.5cm. Of these, six (9.5%) declined intervention, 18 (28.6%) were turned down for surgical intervention due to comorbidities. Those turned down for surgery had an average of 3.5 mFI items. Elective AAA repair patients for the same period had an average of 1.4 mFI items. Conclusion: The study shows that a Standardised Frailty Index Scoring System correlated closely with senior clinician decision making. While there is no substitute for clinical experience, such an objective scoring system could aid a surgeon's decision and also provide medico-legal protection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.